ºÚÁÏÍø

ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
ºÚÁÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 2975

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Evaluation of human epidermal growth factor receptor (HER-2/neu) in gastric adenocarcinoma: A study from South Asia region

12th International Conference on Pediatric Pathology & Laboratory Medicine

Asma Shabbir, Muhammad Asif Qureshi, Talat Mirza and Abdullah Bin Khalid

Jinnah Sindh Medical University, Pakistan

ScientificTracks Abstracts: J Clin Exp Pathol

DOI:

Abstract
Background & Aim: Gastric cancer is the third leading cause of cancer mortality worldwide. Human epidermal growth factor (HER- 2/neu) has shown strong therapeutic implication in breast cancer. Expression of HER-2/neu in gastric cancer has been reported from across the world, it is still unknown from South Asia region. The aim of this study is to evaluate HER-2/neu expression in gastric adenocarcinomas and to correlate with various clinicopathological variables. Patients & Method: A total of 95 consecutive patients undergoing endoscopic biopsy or gastrectomy were recruited in this study after institutional ethical approval. Clinicopathological parameters of all patients were recorded and hematoxylin and eosin (H&E) staining was performed. Expression of HER-2/neu was investigated by immunohistochemistry using �±-HER-2 antibody. Hofmann validation scoring system was used and its association was seen with various clinicopathological variables including age, gender, histopathological type, grade and stage of the tumor. Results: HER-2/neu over expression was found in 21 (22.1%) cases from the total of 95 gastric adenocarcinomas. HER-2/neu was significantly expressed in low grade gastric cancer (p=0.030). Although there was no significant difference between HER-2/neu expression and other variables, HER-2/neu score 3+ was higher in females, age >60 years, Laurens intestinal type and IIIC stage. Conclusion: HER-2/neu is expressed in a limited group of gastric cancer patients in Pakistani population. Our findings indicate a significant strong association of HER-2/neu expression with low grades of gastric cancer.
Biography

Asma Shabbir has done her MBBS from B J Medical College, Pune, India. She has done her Post-graduation from Dow International Medical College, Karachi, Pakistan. She has a passion towards research and concerned for better prognosis of the patient. She has presented her research work in many conferences. Recently, she received the Young Researcher Award at the International Conference of Digestive Diseases in Dubai 2016. She is a member of different scientific and research associations. At present, she is working as a Researcher and as an Assistant Professor in the Department of Pathology, Jinnah Sindh Medical University, Pakistan.

Email: drasma52@gmail.com

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top